Cellectis Statistics
Total Valuation
Cellectis has a market cap or net worth of $93.20 million. The enterprise value is $35.80 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, after market close.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Cellectis has 72.09 million shares outstanding. The number of shares has increased by 58.85% in one year.
Current Share Class | n/a |
Shares Outstanding | 72.09M |
Shares Change (YoY) | +58.85% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 39.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.89 |
Forward PS | 1.68 |
PB Ratio | 0.71 |
P/TBV Ratio | 0.72 |
P/FCF Ratio | 4.57 |
P/OCF Ratio | 4.05 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.73 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1.75 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.67.
Current Ratio | 1.73 |
Quick Ratio | 1.00 |
Debt / Equity | 0.67 |
Debt / EBITDA | n/a |
Debt / FCF | 4.33 |
Interest Coverage | -7.99 |
Financial Efficiency
Return on equity (ROE) is -34.08% and return on invested capital (ROIC) is -19.21%.
Return on Equity (ROE) | -34.08% |
Return on Assets (ROA) | -10.37% |
Return on Invested Capital (ROIC) | -19.21% |
Return on Capital Employed (ROCE) | -27.41% |
Revenue Per Employee | $221,698 |
Profits Per Employee | -$165,590 |
Employee Count | 222 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.13% in the last 52 weeks. The beta is 3.28, so Cellectis's price volatility has been higher than the market average.
Beta (5Y) | 3.28 |
52-Week Price Change | -51.13% |
50-Day Moving Average | 1.41 |
200-Day Moving Average | 1.85 |
Relative Strength Index (RSI) | 46.27 |
Average Volume (20 Days) | 839,274 |
Short Selling Information
Short Interest | 220,035 |
Short Previous Month | 237,569 |
Short % of Shares Out | 0.27% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, Cellectis had revenue of $49.22 million and -$36.76 million in losses. Loss per share was -$0.41.
Revenue | 49.22M |
Gross Profit | 49.22M |
Operating Income | -59.56M |
Pretax Income | -80.31M |
Net Income | -36.76M |
EBITDA | -48.25M |
EBIT | -59.56M |
Loss Per Share | -$0.41 |
Full Income Statement Balance Sheet
The company has $143.25 million in cash and $88.27 million in debt, giving a net cash position of $54.98 million or $0.76 per share.
Cash & Cash Equivalents | 143.25M |
Total Debt | 88.27M |
Net Cash | 54.98M |
Net Cash Per Share | $0.76 |
Equity (Book Value) | 131.03M |
Book Value Per Share | 1.82 |
Working Capital | 120.80M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $22.99 million and capital expenditures -$2.58 million, giving a free cash flow of $20.41 million.
Operating Cash Flow | 22.99M |
Capital Expenditures | -2.58M |
Free Cash Flow | 20.41M |
FCF Per Share | $0.28 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of -121.00% and -74.69%.
Gross Margin | 100.00% |
Operating Margin | -121.00% |
Pretax Margin | -74.69% |
Profit Margin | -74.69% |
EBITDA Margin | -98.04% |
EBIT Margin | -121.00% |
FCF Margin | 41.46% |
Dividends & Yields
Cellectis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -58.85% |
Shareholder Yield | -58.85% |
Earnings Yield | -39.45% |
FCF Yield | 21.90% |
Analyst Forecast
The average price target for Cellectis is $7.00, which is 430.30% higher than the current price. The consensus rating is "Buy".
Price Target | $7.00 |
Price Target Difference | 430.30% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 27.62% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Cellectis has an Altman Z-Score of -0.73 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.73 |
Piotroski F-Score | 5 |